Publications by authors named "Yuu Ogihara"
Article Synopsis
- The study reports two cases of gastric cancer (GC) patients with elevated serum levels of a biomarker, Krebs von den Lungen-6 (sKL-6), who were treated with SOX chemotherapy, which combines oxaliplatin and S-1.
- The first patient, a 79-year-old woman, showed a significant reduction in both her tumor and sKL-6 levels after chemotherapy, remaining metastasis-free for 72 months despite experiencing interstitial pneumonia later on.
- The second patient, a 69-year-old woman, also had a decrease in tumor size and sKL-6 levels after receiving SOX therapy combined with trastuzumab, indicating potential effectiveness of the treatments despite high initial biomarker levels
Background: Many types of tumors can arise in the esophagogastric junction (EGJ). Squamous cell carcinoma (SCC) arising from the esophageal epithelia, adenocarcinoma arising from the gastric mucosa, or Barrett's esophageal mucosa are frequently observed in the EGJ. However, adenosquamous carcinoma (ASC) has been rarely observed in this area.
View Article and Find Full Text PDF